Skip to content

Brian E Grunau

2 papers in the library · publishing 2010

Papers

Sort Most recent Most cited

Dantrolene for the treatment of MDMA toxicity.

CJEM September 2010 Brian E Grunau, Matthew O Wiens, Marc Greidanus

MDMA (3,4-methylenedioxymethamphetamine), popularly known as “Ecstasy,” was first introduced and patented by Merck & Co., Inc., in 1914 as an appetite suppressant. Currently, its primary role is as an illegal stimulant used to produce a euphoric effect during parties. This case report de scribes a 31-year-old man who, after taking 3 tablets of Ecstasy, presented to an emergency department with...

Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review.

CJEM September 2010 Brian E Grunau, Matthew O Wiens, Jeffrey R Brubacher

The use of dantrolene in the treatment of hyperpyrexia related to MDMA (3,4-methylenedioxymethamphetamine) is controversial, with little data available to guide clinical decision-making. Although the treatment is recommended by several poison control centres, published data are primarily in the form of case reports and animal and in vitro experiments. We conducted a systematic review to...